Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from http://www.ncbi.nlm.nih.gov/pubmed/32173574 below:

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Meta-Analysis

Affiliations

• ¹ Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; The First Clinical Medical School of Lanzhou University, Lanzhou, China.
• ² Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; Key Laboratory for Gastrointestinal Diseases of Gansu Province, The First Hospital of Lanzhou University, Lanzhou, China.
• ³ Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; Gastrointestinal Endoscopy Center, Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China.
• ⁴ Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; Key Laboratory for Gastrointestinal Diseases of Gansu Province, The First Hospital of Lanzhou University, Lanzhou, China; Gastrointestinal Endoscopy Center, Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China.
• ⁵ The First Clinical Medical School of Lanzhou University, Lanzhou, China.
• ⁶ Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; Key Laboratory for Gastrointestinal Diseases of Gansu Province, The First Hospital of Lanzhou University, Lanzhou, China. Electronic address: wangyuping@lzu.edu.cn.
• ⁷ Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; Key Laboratory for Gastrointestinal Diseases of Gansu Province, The First Hospital of Lanzhou University, Lanzhou, China; Gastrointestinal Endoscopy Center, Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China. Electronic address: zhouyn@lzu.edu.cn.

• PMID: 32173574
• PMCID: PMC7194638
• DOI: 10.1016/j.ijid.2020.03.017

Item in Clipboard

Meta-Analysis

Jing Yang et al. Int J Infect Dis. 2020 May.

• ¹ Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; The First Clinical Medical School of Lanzhou University, Lanzhou, China.
• ² Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; Key Laboratory for Gastrointestinal Diseases of Gansu Province, The First Hospital of Lanzhou University, Lanzhou, China.
• ³ Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; Gastrointestinal Endoscopy Center, Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China.
• ⁴ Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; Key Laboratory for Gastrointestinal Diseases of Gansu Province, The First Hospital of Lanzhou University, Lanzhou, China; Gastrointestinal Endoscopy Center, Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China.
• ⁵ The First Clinical Medical School of Lanzhou University, Lanzhou, China.
• ⁶ Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; Key Laboratory for Gastrointestinal Diseases of Gansu Province, The First Hospital of Lanzhou University, Lanzhou, China. Electronic address: wangyuping@lzu.edu.cn.
• ⁷ Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; Key Laboratory for Gastrointestinal Diseases of Gansu Province, The First Hospital of Lanzhou University, Lanzhou, China; Gastrointestinal Endoscopy Center, Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China. Electronic address: zhouyn@lzu.edu.cn.

• PMID: 32173574
• PMCID: PMC7194638
• DOI: 10.1016/j.ijid.2020.03.017

Item in Clipboard

Background: An outbreak of coronavirus disease 2019 (COVID-19) occurred in Wuhan, China; the epidemic is more widespread than initially estimated, with cases now confirmed in multiple countries.

Aims: The aim of this meta-analysis was to assess the prevalence of comorbidities in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients and the risk of underlying diseases in severe patients compared to non-severe patients.

Methods: A literature search was conducted using the databases PubMed, EMBASE, and Web of Science through February 25, 2020. Odds ratios (ORs) and 95% confidence intervals (CIs) were pooled using random-effects models.

Results: Seven studies were included in the meta-analysis, including 1 576 infected patients. The results showed the most prevalent clinical symptom was fever (91.3%, 95% CI: 86-97%), followed by cough (67.7%, 95% CI: 59-76%), fatigue (51.0%, 95% CI: 34-68%) and dyspnea (30.4%, 95% CI: 21-40%). The most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0-27.2%) and diabetes (9.7%, 95% CI: 7.2-12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8-13.8%) and respiratory system disease (1.5%, 95% CI: 0.9-2.1%). When compared between severe and non-severe patients, the pooled OR of hypertension, respiratory system disease, and cardiovascular disease were 2.36 (95% CI: 1.46-3.83), 2.46 (95% CI: 1.76-3.44) and 3.42 (95% CI: 1.88-6.22) respectively.

Conclusion: We assessed the prevalence of comorbidities in the COVID-19 patients and found that underlying disease, including hypertension, respiratory system disease and cardiovascular disease, may be risk factors for severe patients compared with non-severe patients.

Keywords: COVID-19; Clinical characteristics; Comorbidities; Epidemiology; Meta-analysis; SARS-CoV-2.

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

PubMed Disclaimer

Flow diagram of the number…

Flow diagram of the number of studies screened and included in the meta-analysis.

Flow diagram of the number of studies screened and included in the meta-analysis.

Meta-analysis of the comorbidities in…

Meta-analysis of the comorbidities in COVID-19 cases. A, B, C, D represent proportions…

Meta-analysis of the comorbidities in COVID-19 cases. A, B, C, D represent proportions of hypertension, diabetes, respiratory system disease, and cardiovascular disease.

The risk of comorbidities in…

The risk of comorbidities in severe patients compared to non-severe patients. (A) hypertension,…

The risk of comorbidities in severe patients compared to non-severe patients. (A) hypertension, (B) diabetes, (C) respiratory system disease, (D) cardiovascular disease.

• COVID-19 and non-communicable diseases.

  Pal R, Bhadada SK. Pal R, et al. Postgrad Med J. 2020 Jul;96(1137):429-430. doi: 10.1136/postgradmedj-2020-137742. Epub 2020 Mar 30. Postgrad Med J. 2020. PMID: 32234837 Free PMC article. No abstract available.

• Prevalence of Cardiovascular Comorbidities in Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Pooled Analysis of Published Data.

  Liu Y, Wu S, Qin M, Jiang W, Liu X. Liu Y, et al. J Am Heart Assoc. 2020 Sep;9(17):e016812. doi: 10.1161/JAHA.120.016812. Epub 2020 Jul 15. J Am Heart Assoc. 2020. PMID: 32673529 Free PMC article. Review.

• Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.

  Xiong S, Liu L, Lin F, Shi J, Han L, Liu H, He L, Jiang Q, Wang Z, Fu W, Li Z, Lu Q, Chen Z, Ding S. Xiong S, et al. BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2. BMC Infect Dis. 2020. PMID: 33092539 Free PMC article.

• Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.

  Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, Demertzis Z, Hanna Z, Failla A, Dagher C, Chaudhry Z, Vahia A, Abreu Lanfranco O, Ramesh M, Zervos MJ, Alangaden G, Miller J, Brar I. Suleyman G, et al. JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.

• Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis.

  Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, Wu Y, Sun L, Xu Y. Hu Y, et al. J Clin Virol. 2020 Jun;127:104371. doi: 10.1016/j.jcv.2020.104371. Epub 2020 Apr 14. J Clin Virol. 2020. PMID: 32315817 Free PMC article.

• Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis.

  Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Sun P, et al. J Med Virol. 2020 Jun;92(6):612-617. doi: 10.1002/jmv.25735. Epub 2020 Mar 11. J Med Virol. 2020. PMID: 32108351 Free PMC article.

• SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?

  Mazucanti CH, Egan JM. Mazucanti CH, et al. Immun Ageing. 2020 Jun 30;17:21. doi: 10.1186/s12979-020-00192-y. eCollection 2020. Immun Ageing. 2020. PMID: 32612666 Free PMC article. Review.

• Influence of inhibitors of the renin-angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients.

  Holt A, Mizrak I, Lamberts M, Lav Madsen P. Holt A, et al. J Hypertens. 2020 Aug;38(8):1612-1613. doi: 10.1097/HJH.0000000000002515. J Hypertens. 2020. PMID: 32687274 Free PMC article. No abstract available.

• Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19.

  Johnson KD, Harris C, Cain JK, Hummer C, Goyal H, Perisetti A. Johnson KD, et al. Front Med (Lausanne). 2020 Aug 13;7:526. doi: 10.3389/fmed.2020.00526. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32903492 Free PMC article. Review.

• Personal and vaccination history as factors associated with SARS-CoV-2 infection.

  Fernández-Prada M, García-González P, García-Morán A, Ruiz-Álvarez I, Ramas-Diez C, Calvo-Rodríguez C. Fernández-Prada M, et al. Med Clin (Barc). 2021 Sep 10;157(5):226-233. doi: 10.1016/j.medcli.2021.02.011. Epub 2021 Mar 19. Med Clin (Barc). 2021. PMID: 33966881 Free PMC article. English, Spanish.

• Development of a quantitative segmentation model to assess the effect of comorbidity on patients with COVID-19.

  Zhang C, Yang G, Cai C, Xu Z, Wu H, Guo Y, Xie Z, Shi H, Cheng G, Wang J. Zhang C, et al. Eur J Med Res. 2020 Oct 12;25(1):49. doi: 10.1186/s40001-020-00450-1. Eur J Med Res. 2020. PMID: 33046116 Free PMC article.

1. 1. Alraddadi B.M., Watson J.T., Almarashi A., Abedi G.R., Turkistani A., Sadran M. Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerging Infect Dis. 2016;22:49–55. - PMC - PubMed
2. 1. Badawi A., Ryoo S.G. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016;49:129–133. - PMC - PubMed
3. 1. Channappanavar R., Fett C., Mack M., Ten Eyck P.P., Meyerholz D.K., Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol. 2017;198:4046–4053. - PMC - PubMed
4. 1. Dooley K.E., Chaisson R.E. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9:737–746. - PMC - PubMed
5. 1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3